|
1.
» Patients Listen to Mesothelioma Survivor Speak at Teleconference ... Dec 21, 2006 ... The cancer was so widespread that doctors told him there was little hope ... “Surviving Mesothelioma and Other Cancers - A Patient’s Guide. ... 2.
» Asbestos verdict nets $4.2 million; Award for San Ramon terminal ... Jul 30, 2002 ... Trinchese was diagnosed in August; he sued in October, claiming Union Carbide was negligent in manufacturing asbestos-containing Bakelite ... 3.
Pleural Mesothelioma Jan 26, 2007 ... Malignant pleural mesothelioma Pleural Mesothelioma as compared to a healthy lung. is the most common type of mesothelioma, making up over ... 4.
Peritoneal Mesothelioma (Abdominal Mesothelioma) Jan 26, 2007 ... Malignant peritoneal mesothelioma Abdominal cavity showing the location of the peritoneum; peritoneal mesothelioma. ... 5.
Mesothelioma Doctor > The Mesothelioma Center Jun 10, 2008 ... Harvey Pass, MD. Professor, Department of Cardiothoracic Surgery. NYU Medical Center, NYU. 160 East 34th Street New York, NY 10016 ... Show map of 160 E 34th St, New York, NY 10016 6.
Mesothelioma Doctor > The Mesothelioma Center Jun 10, 2008 ... Harvey Pass, MD. Professor, Department of Cardiothoracic Surgery. NYU Medical Center, NYU. 160 East 34th Street New York, NY 10016 ... Show map of 160 E 34th St, New York, NY 10016 7.
» New York State Labor Department Suspends Rochester Asbestos ... Jun 24, 2008 ... The New York State Department of Labor has issued a “Suspension of Asbestos Project” notice to Gordon Smith Contracting, due to numerous ... 8.
» Asbestos hazards prompt EPA to halt demolition work ... Sep 19, 2008 ... According to inspectors, this work could create an environmental and health hazard by disturbing suspect asbestos materials and also ... 9.
» Zengen, Inc. - Mesothelioma News Dec 17, 2008 ... Wednesday, March 3rd, 2004 - Zengen’s new study reviews novel approach to control inflammation using melanocortin receptors; Study supports ... 10.
» Zengen, Inc. - Mesothelioma News Dec 17, 2008 ... Zengen, Inc. news feed. Wednesday, March 3rd, 2004 - Zengen’s new study reviews novel approach to control inflammation using melanocortin ... |
